Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of Circulating Endothelial Progenitor Cells CD34+144+CD14- and CD34+VEGF-R2+CD14- in the Follow-up of Aortic Aneurysm

NCT01918982 is registered in ClinicalTrials.gov with Hopital Jean Minjoz as lead sponsor.

NCT NCT01918982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01918982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of Circulating Endothelial Progenitor Cells CD34+144+CD14- and CD34+VEGF-R2+CD14- in the Follow-up of Aortic Aneurysm
Lead sponsor
Hopital Jean Minjoz
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2013
Completion date
May 31, 2016
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

- aortic aneurysm